Overview

A Study of Florbetapir (18F) in Japanese Healthy Volunteers

Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
This study will determine how florbetapir (18F) (18F-AV-45) radioactivity is distributed throughout the body of Japanese subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Avid Radiopharmaceuticals
Collaborator:
Eli Lilly and Company